‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews a series of posters on the topic of Parkinson’s disease (PD) presented at the 7th Congress of the European Academy of Neurology (EAN) 2021. Posters presented included real-world data on the efficacy and safety of emerging treatments for patients with PD, with a focus on opicapone (ONGENTYS®, Bial, Trofa, Portugal), a catechol-O-methyltransferase inhibitor developed to manage motor fluctuations, symptoms that severely impact patient quality of life.
Allergy & Immunology
